Analysts' Actions: ORCL, LOW, LUV


Cabot ( CBT) upgraded at Jefferies to Buy from Hold, Jefferies said. $50 price target. Favorable EPS revisions and structural change at a discount.

Carbo Ceramics ( CRR) upgraded at Morgan Stanley from Underweight to Equal-weight, Morgan Stanley said. $125 price target. Channel checks suggest that demand concerns are overblown.

Fidelity Bancorp ( FSBI) downgraded to sell at TheStreet Ratings.

Lowe's ( LOW) upgraded at Nomura from Neutral to Buy, Nomura said. $40 price target. Estimates also boosted, as the company is cutting costs.

Soutwest Airlines ( LUV) downgraded at BofA/Merrill Lynch to Neutral, Bank of America/Merrill Lynch said. $9 price target. Sales growth could lag peers through the Spring.

Allscripts ( MDRX) rated new Outperform at Credit Suisse. Company continues to expand its product portfolio. $23 price target.

MarineMax ( HZO) downgraded to sell at TheStreet Ratings.

Nike ( NKE) downgraded at McAdams from Hold to Sell, McAdams Wright Ragen said. Valuation call.

Oracle ( ORCL) downgraded at Jefferies to Hold from Buy, Jefferies said. $32 price target. Increasing challenges to growth. Hold rating.

Quality Systems ( QSII) rated new Neutral at Credit Suisse. Valuation call, based on a $47 price target.

Sherwin Williams ( SHW) rated new Buy at Nomura. $137 price target. A defensible niche coupled with pricing power and convenient stores.

Sonoco Products ( SON) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. $31 price target. Company faces earnings headwinds.

Theravance ( THRX) rated new Buy at Brean Murray. $24 price target. GSK respiratory franchise should help drive growth.

Under Armour ( UA) downgraded at Sterne Agee from Buy to Neutral, Sterne Agee said. Valuation call, as the stock is trading at 32x 2013 earnings.

United Continental ( UAL) downgraded at BofA/Merrill to Neutral, Bank of America/Merrill Lynch said. Oil is rising and bookings momentum has stalled. $26 price target.


Ann ( ANN) estimates, target raised at FBR. Shares of ANN now seen reaching $30, according to FBR Capital Markets. Estimates also increased, to match the company's new guidance. Outperform rating.

Chesapeake Midstream ( CHKM) estimates lowered at UBS through 2013, UBS said. Updating numbers post 4Q11 results and 10K. Buy rating and $32 price target.

Crocs ( CROX) estimates, target increased at Stifel. CROX estimates were raised through 2013, Stifel Nicolaus said. Company has significant leverage potential. New $23 price target.

If you liked this article you might like

7 Essential Rules for Investing in Tech Stocks

Tax Reform Is Coming and That Means Trump Stock Rally Is Ready to Kill It Again

'Trump Stock' Rally Is Back on Track

Crazy Weak U.S. Dollar Will Make These 10 Companies Huge Winners

Dow, S&P 500 Set New Records as Fed Moves to Unwind Balance Sheet